We are live on ! Find out more
KRTX

Karuna Therapeutics, Inc. Common Stock
KRTX

Delisted

KRTX was delisted on the 15th of March, 2024.

Back to rankings

2 hedge funds and large institutions have $270K invested in Karuna Therapeutics, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 325 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less funds holding

Funds holding: 328 → 2 (-326)

100% less funds holding in top 10

Funds holding in top 10: 26 → 0 (-26)

100% less capital invested

Capital invested by funds: $12B → $270K (-$12B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 325

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
2
Holders Change
-326
Holders Change %
-99.39%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
-26
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
325
Calls
$2K
Puts
–
Net Calls
+$2K
Net Calls Change
-$46.5M

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Capital International Investors
Capital International Investors
California
-$1.34B
2
Vanguard Group
Vanguard Group
Pennsylvania
-$1.02B
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$907M
4
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
-$858M
5
BlackRock
BlackRock
New York
-$638M
Name Holding Trade Value Shares
Change 		Change in
Stake
WAM
276
Wolverine Asset Management
Illinois
– -$127K -400 Closed
TRCT
277
Tower Research Capital (TRC)
New York
– -$106K -334 Closed
CG
278
Cutler Group
California
– -$94K -300 Closed
Nisa Investment Advisors
279
Nisa Investment Advisors
Missouri
– -$87K -275 Closed
Carson Wealth (CWM LLC)
280
Carson Wealth (CWM LLC)
Nebraska
– -$86K -272 Closed
LC
281
Lindbrook Capital
California
– -$75.3K -238 Closed
PA
282
Parallel Advisors
California
– -$75.3K -238 Closed
PNC Financial Services Group
283
PNC Financial Services Group
Pennsylvania
– -$63.9K -202 Closed
SSG
284
Summit Securities Group
New York
– -$63K -200 Closed
FHA
285
First Horizon Advisors
Tennessee
– -$51.3K -162 Closed
Daiwa Securities Group
286
Daiwa Securities Group
Japan
– -$49K -154 Closed
Parallax Volatility Advisers
287
Parallax Volatility Advisers
California
– -$46.8K -148 Closed
Russell Investments Group
288
Russell Investments Group
United Kingdom
– -$40.2K -127 Closed
ASN
289
Advisory Services Network
Georgia
– -$37.7K -119 Closed
QCG
290
Quadrant Capital Group
Ohio
– -$32.6K -103 Closed
SAM
291
Smartleaf Asset Management
Massachusetts
– -$31.6K -100 Closed
NA
292
NewEdge Advisors
Louisiana
– -$29.4K -93 Closed
EWA
293
EverSource Wealth Advisors
Alabama
– -$27.9K -88 Closed
CTC
294
Central Trust Company
Missouri
– -$23.7K -75 Closed
ACM
295
Accent Capital Management
Ohio
– -$20.6K -65 Closed
HWM
296
HighMark Wealth Management
Minnesota
– -$17.4K -55 Closed
Mitsubishi UFJ Asset Management
297
Mitsubishi UFJ Asset Management
Japan
– -$13.8K -44 Closed
C
298
Covestor
United Kingdom
– -$13K -41 Closed
GI
299
GAMMA Investing
California
– -$12.8K -41 Closed
GRP
300
Global Retirement Partners
California
– -$11.7K -37 Closed
10 11
12
13 14

KRTX Hedge Fund Activity: Q1 2024 in Review

2 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Karuna Therapeutics, Inc. Common Stock (KRTX) for Q1 2024, worth a combined $270K — down 100% from $12B a quarter earlier.

Sellers outnumbered buyers: 325 funds closed out of KRTX and 0 opened new positions — a net loss of 325 holders — while 1 trimmed existing stakes and 0 added.

The largest seller was Capital International Investors, exiting entirely with an estimated $1.34B sold.

  • 2 institutional investors held Karuna Therapeutics, Inc. Common Stock (KRTX) as of Q1 2024, down from 328 in Q4 2023.
  • Funds reported $270K of Karuna Therapeutics, Inc. Common Stock stock for Q1 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Karuna Therapeutics, Inc. Common Stock positions in Q1 2024 and 325 closed out, a net change of -325 holders.
  • The largest Karuna Therapeutics, Inc. Common Stock seller in Q1 2024 was Capital International Investors, an estimated $1.34B sold.

Based on aggregated 13F filings for Q1 2024.